We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Translation of Omic Data into Personalised Oncology Tools The Challenge and the Reward

Video   Aug 18, 2015

 

About the Speaker


Prof. Gallagher is currently the Chief Scientific Officer (CSO) at OncoMark. A major focus of Prof. Gallagher’s research work is the identification and validation of candidate biomarkers of breast cancer and melanoma, with particular emphasis on translation of transcriptomic and proteomic datasets into clinically relevant assays. In addition, his team (the Cancer Biology and Therapeutics Lab; www.cbtlab.ie) investigates the functional relevance of candidate tumour progression-associated genes at both in vitro and in vivo levels, as well as engages in preclinical evaluation of novel anti-cancer agents.Abstract
This presentation will cover how bottlenecks in the validation of candidate tumour progression-related biomarkers can be overcome. In particular, the use of tissue microarray technology and digital pathology will be highlighted. In addition, a novel mechanistically anchored biomarker panel that outcompetes current prognostic classifiers in breast cancer will be introduced for the first time.

 
 
 
Advertisement
 

Recommended Videos

The Thermo Scientific Orbitrap Exploris 240 Mass Spectrometer Fast Tracks Your Path to High-confidence Discovery and Identification

Video

Meet the Orbitrap Exploris 240 mass spectrometer: leading performance, application versatility and intelligent data acquisition enable exceptional data quality that is synonymous with Thermo Scientific Orbitrap technology.

WATCH NOW

Teach Me in 10 - CRISPR, Cell Therapies and Drug Discovery With Dr Theo Roth

Video

This instalment of Teach Me in 10 features Dr Theo Roth, whose work bridges a number of different fields, such as genome engineering, cancer immunology and cell-based therapies.

WATCH NOW

First Volunteers Receive Imperial COVID-19 Vaccine

Video

The first healthy volunteers have now received a candidate coronavirus vaccine developed by Imperial researchers.

WATCH NOW

 

Like what you just watched? You can find similar content on the communities below.

Cancer Research Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE